EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

SUMOylation Modulates Reactive Oxygen Species (ROS) Levels and Acts as a Protective Mechanism in the Type 2 Model of Diabetic Peripheral Neuropathy

Nicolas Mandel, Michael Büttner, Gernot Poschet iD, Rohini Kuner, Nitin Agarwal

Cells · 2023

DOI: 10.3390/cells12212511 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Cells, 2023. Verfasst von Nicolas Mandel und 4 weiteren Autor:innen. Beteiligte Einrichtung: Institute of Pharmacology, Medical Faculty Heidelberg, Heidelberg University, Im Neuenheimer Feld 366, 69120 Heidelberg, Germany. Hauptthemen laut MEDLINE: Diabetic Neuropathies, Diabetes Mellitus, Experimental, Diabetes Mellitus, Type 2. Die Arbeit wurde bisher 14-mal zitiert (Crossref) und nennt 72 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Deutsche Forschungsgemeinschaft.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Diabetic peripheral neuropathy (DPN) is the prevalent type of peripheral neuropathy; it primarily impacts extremity nerves. Its multifaceted nature makes the molecular mechanisms of diabetic neuropathy intricate and incompletely elucidated. Several types of post-translational modifications (PTMs) have been implicated in the development and progression of DPN, including phosphorylation, glycation, acetylation and SUMOylation. SUMOylation involves the covalent attachment of small ubiquitin-like modifier (SUMO) proteins to target proteins, and it plays a role in various cellular processes, including protein localization, stability, and function. While the specific relationship between high blood glucose and SUMOylation is not extensively studied, recent evidence implies its involvement in the development of DPN in type 1 diabetes. In this study, we investigated the impact of SUMOylation on the onset and progression of DPN in a type 2 diabetes model using genetically modified mutant mice lacking SUMOylation, specifically in peripheral sensory neurons (SNS-Ubc9−/−). Behavioural measurement for evoked pain, morphological analyses of nerve fibre loss in the epidermis, measurement of reactive oxygen species (ROS) levels, and antioxidant molecules were analysed over several months in SUMOylation-deficient and control mice. Our longitudinal analysis at 30 weeks post-high-fat diet revealed that SNS-Ubc9−/− mice exhibited earlier and more pronounced thermal and mechanical sensation loss and accelerated intraepidermal nerve fibre loss compared to control mice. Mechanistically, these changes are associated with increased levels of ROS both in sensory neuronal soma and in peripheral axonal nerve endings in SNS-Ubc9−/− mice. In addition, we observed compromised detoxifying potential, impaired respiratory chain complexes, and reduced levels of protective lipids in sensory neurons upon deletion of SUMOylation in diabetic mice. Importantly, we also identified mitochondrial malate dehydrogenase (MDH2) as a SUMOylation target, the activity of which is negatively regulated by SUMOylation. Our results indicate that SUMOylation is an essential neuroprotective mechanism in sensory neurons in type 2 diabetes, the deletion of which causes oxidative stress and an impaired respiratory chain, resulting in energy depletion and subsequent damage to sensory neurons.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Diabetic NeuropathiesDiabetes Mellitus, ExperimentalDiabetes Mellitus, Type 2MiceAnimalsReactive Oxygen SpeciesSumoylationSensory Receptor Cells

Stichwörter der Autor:innen

SUMOylationhigh-fat diethyperglycaemiamalate dehydrogenase 2reactive oxygen speciesrespiratory chain

Substanzen

Reactive Oxygen Species

Autor:innen und Institutionen

  • Institute of Pharmacology, Medical Faculty Heidelberg, Heidelberg University, Im Neuenheimer Feld 366, 69120 Heidelberg, Germany.
  • Centre for Organismal Studies (COS), University of Heidelberg, Im Neuenheimer Feld 360, 69120 Heidelberg, Germany.

ORCID-Profile: Gernot Poschet

Förderung

  • Deutsche Forschungsgemeinschaft

Zitieren

APA

Mandel, N., Büttner, M., Poschet, G., Kuner, R., & Agarwal, N. (2023). SUMOylation Modulates Reactive Oxygen Species (ROS) Levels and Acts as a Protective Mechanism in the Type 2 Model of Diabetic Peripheral Neuropathy. Cells. https://doi.org/10.3390/cells12212511

Vancouver

Mandel N, Büttner M, Poschet G, Kuner R, Agarwal N. SUMOylation Modulates Reactive Oxygen Species (ROS) Levels and Acts as a Protective Mechanism in the Type 2 Model of Diabetic Peripheral Neuropathy. Cells. 2023. doi:10.3390/cells12212511

BibTeX
@article{Mandel2023,
  author = {Mandel, Nicolas and Büttner, Michael and Poschet, Gernot and Kuner, Rohini and Agarwal, Nitin},
  title = {SUMOylation Modulates Reactive Oxygen Species (ROS) Levels and Acts as a Protective Mechanism in the Type 2 Model of Diabetic Peripheral Neuropathy},
  journal = {Cells},
  year = {2023},
  doi = {10.3390/cells12212511}
}
Kostenlos starten →